Indications and uses
Uses for temporary relief of minor asthma symptoms such as: shortness of breath tightness in chest wheezing bronchial irritation cough minor breathing difficulties as per various homeopathic Materia Medicas.
AsthmaCare
- Manufacturer
- King Bio Inc.
- Effective date
- 2012-02-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:03:33
Label at a glance#
ProductAsthmaCare
Active ingredientACONITUM NAPELLUS, EPINEPHRINE, AMMONIUM CARBONATE, ANTIMONY POTASSIUM TARTRATE, ARALIA RACEMOSA ROOT, BROMINE, CHLORINE, ERIODICTYON CALIFORNICUM LEAF, EUCALYPTUS GLOBULUS LEAF, GRINDELIA HIRSUTULA FLOWERING TOP, LOBELIA INFLATA, SODIUM SULFATE, PHOSPHORUS, QUEBRACHO BARK, TRIFOLIUM PRATENSE FLOWER
Label structure8 sections
Dosage and administration
Directions Initially, depress pump until primed. Hold close to mouth and spray one dose directly into mouth. Adult Dose 3 pump sprays 3 times per day. Children 6 - 12 years 2 pump sprays 3 times per day. Use additionally as needed, up to 6 times per day. Reference image asthmacare.jpg
Contacts and useful links#
Websitewww.safe-care.com
www.safe-care.com
www.safe-care.comLabel contents#
Full prescribing information#
Active Ingredients
HPUS active ingredients
Equal volumes of each ingredient in 10X, 30X and LM1 potencies.
Aconitum napellus
Adrenalinum
Ammonium carbonicum
Antimonium tartaricum
Aralia racemosa
Bromium
Chlorinum
Eriodictyon californicum
Eucalyptus globulus
Grindelia
Lobelia inflata
Natrum sulphuricum
Phosphorus
Quebracho
Trifolium pratense
Reference image asthmacare.jpg
Inactive Ingredients
Purified water, potassium sorbate and citric acid.
Reference image asthmacare.jpg
Purpose
HPUS active ingredients Purpose
Equal volumes of each ingredient in 10X, 30X and LM1 potencies.
Aconitum napellus....................................................................shortness of breath
Adrenalinum.............................................................................asthma related congestion
Ammonium carbonicum............................................................breathing difficulties
Antimonium tartaricum.............................................................shortness of breath
Aralia racemosa.......................................................................tightness in chest
Bromium.................................................................................spasmodic cough
Chlorinum................................................................................tightness in chest
Eriodictyon californicum...........................................................asthmatic wheezing
Eucalyptus globulus.................................................................mucus congestion
Grindelia.................................................................................bronchial irritation
Lobelia inflata..........................................................................cough, chest discomfort
Natrum sulphuricum................................................................shortness of breath
Phosphorus............................................................................asthmatic chest spasms
Quebracho.............................................................................shortness of breath
Trifolium pratense...................................................................tracheal irritation
Reference image asthmacare.jpg
Dosage and Administration
Directions Initially, depress pump until primed. Hold close to mouth and spray one dose directly into mouth.
Adult Dose 3 pump sprays 3 times per day.
Children 6 - 12 years 2 pump sprays 3 times per day.
Use additionally as needed, up to 6 times per day.
Reference image asthmacare.jpg
Warnings
- This product is not a rescue inhaler.
- Asthma can be life threatening. If you have ever been hospitalized for asthma, consult a physician before using this product. This product is intended to complement, not replace, standard medical treatment.
- Children with asthma should be under the ongoing supervision of a physician.
- Stop use and ask a doctor if symptoms persist or worsen.
- If pregnant or breast-feeding, ask a healthcare professional before use. Keep out of reach of children.
Tamper resistant for your protection. Use only if safety seal is intact.
Reference image asthmacare.jpg
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
Reference image asthmacare.jpg
Indications and Usage
Uses for temporary relief of minor asthma symptoms such as:
- shortness of breath
- tightness in chest
- wheezing
- bronchial irritation
- cough
- minor breathing difficulties
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57955-4044-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-58ae-f424-e053-dadaa90a57ce | AsthmaCare |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57955-4044-2 | AsthmaCare | 1 in 1 CARTON | LIQUID | 1 | 1 | |
| 57955-4044-2 | AsthmaCare | 59 mL in 1 BOTTLE, SPRAY | LIQUID | 59 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57955-4044 | ASTHMACARE (SAFECARE) LIQUID [KING BIO INC. ] | 1 | Legacy NDC, 2 package rows | 20120221_3abb2630-6993-41c2-98e4-5a105b6fcf56.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACONITUM NAPELLUS | ACTIVE INGREDIENT | U0NQ8555JD | 1 | |
| AMMONIUM CARBONATE | ACTIVE INGREDIENT | NJ5VT0FKLJ | 1 | |
| ANTIMONY POTASSIUM TARTRATE | ACTIVE INGREDIENT | DL6OZ476V3 | 1 | |
| ARALIA RACEMOSA ROOT | ACTIVE INGREDIENT | T90W4582DU | 1 | |
| BROMINE | ACTIVE INGREDIENT | SBV4XY874G | 1 | |
| CHLORINE | ACTIVE INGREDIENT | 4R7X1O2820 | 1 | |
| EPINEPHRINE | ACTIVE INGREDIENT | YKH834O4BH | 1 | |
| ERIODICTYON CALIFORNICUM LEAF | ACTIVE INGREDIENT | 2Y7TIQ135H | 1 | |
| EUCALYPTUS GLOBULUS LEAF | ACTIVE INGREDIENT | S546YLW6E6 | 1 | |
| GRINDELIA HIRSUTULA FLOWERING TOP | ACTIVE INGREDIENT | IDB0NAZ6AI | 1 | |
| LOBELIA INFLATA | ACTIVE INGREDIENT | 9PP1T3TC5U | 1 | |
| PHOSPHORUS | ACTIVE INGREDIENT | 27YLU75U4W | 1 | |
| QUEBRACHO BARK | ACTIVE INGREDIENT | HST8772GTZ | 1 | |
| SODIUM SULFATE | ACTIVE INGREDIENT | 0YPR65R21J | 1 | |
| TRIFOLIUM PRATENSE FLOWER | ACTIVE INGREDIENT | 4JS0838828 | 1 | |
| ACONITUM NAPELLUS | ACTIVE MOIETY | U0NQ8555JD | 1 | |
| AMMONIUM CATION | ACTIVE MOIETY | 54S68520I4 | 1 | |
| ANTIMONY CATION (3+) | ACTIVE MOIETY | 069647RPT5 | 1 | |
| ARALIA RACEMOSA ROOT | ACTIVE MOIETY | T90W4582DU | 1 | |
| BROMINE | ACTIVE MOIETY | SBV4XY874G | 1 | |
| CHLORINE | ACTIVE MOIETY | 4R7X1O2820 | 1 | |
| EPINEPHRINE | ACTIVE MOIETY | YKH834O4BH | 1 | |
| ERIODICTYON CALIFORNICUM LEAF | ACTIVE MOIETY | 2Y7TIQ135H | 1 | |
| EUCALYPTUS GLOBULUS LEAF | ACTIVE MOIETY | S546YLW6E6 | 1 | |
| GRINDELIA HIRSUTULA FLOWERING TOP | ACTIVE MOIETY | IDB0NAZ6AI | 1 | |
| LOBELIA INFLATA | ACTIVE MOIETY | 9PP1T3TC5U | 1 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | 1 | |
| QUEBRACHO BARK | ACTIVE MOIETY | HST8772GTZ | 1 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 1 | |
| TRIFOLIUM PRATENSE FLOWER | ACTIVE MOIETY | 4JS0838828 | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- AsthmaCare
- Safecare
- ACONITUM NAPELLUS
- EPINEPHRINE
- AMMONIUM CARBONATE
- AMMONIUM CATION
- ANTIMONY POTASSIUM TARTRATE
- ANTIMONY CATION (3+)
- ARALIA RACEMOSA ROOT
- BROMINE
- CHLORINE
- ERIODICTYON CALIFORNICUM LEAF
- EUCALYPTUS GLOBULUS LEAF
- GRINDELIA HIRSUTULA FLOWERING TOP
- LOBELIA INFLATA
- SODIUM SULFATE
- SODIUM CATION
- PHOSPHORUS
- QUEBRACHO BARK
- TRIFOLIUM PRATENSE FLOWER
- WATER
- POTASSIUM SORBATE
- CITRIC ACID MONOHYDRATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 57955-4044 | 57955-4044-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / IONTOPHORESIS | 0.02 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET / ORAL | 6 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / IONTOPHORESIS | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 385 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE, EXTENDED RELEASE / ORAL | 101 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | EMULSION / OPHTHALMIC | 0.47 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CREAM / TOPICAL | 0.25 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAMUSCULAR | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRATHECAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / TOPICAL | 4 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EFFERVESCENT / ORAL | 460 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / INTRAVENOUS | 0.2 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY, METERED / NASAL | 2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE / ORAL | 238 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, COATED / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAMUSCULAR | 28 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SUSPENSION / ORAL | 400 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / SUBLINGUAL | 24 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 608 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CONCENTRATE / ORAL | 5.3 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / RECTAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION, CONCENTRATE / INTRAVENOUS | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INHALANT / RESPIRATORY (INHALATION) | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRABURSAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM / SUBLINGUAL | 10 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / AURICULAR (OTIC) | 0.04 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO / TOPICAL | 17 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INFILTRATION | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SOFT TISSUE | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / TOPICAL | 17 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 700e7133-57d9-448d-acea-69b016f368cd | 3abb2630-6993-41c2-98e4-5a105b6fcf56 | 2012-02-20 | Warnings | 700e7133-57d9-448d-acea-69b016f368cd 3abb2630-6993-41c2-98e4-5a105b6fcf56 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.